Will magnetic resonance imaging (MRI)-based contrast agents for molecular receptor imaging make their way into the clinic?

J Cell Mol Med. Jan-Feb 2008;12(1):187-8. doi: 10.1111/j.1582-4934.2008.00248.x. Epub 2008 Jan 19.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Albumins
  • Animals
  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / metabolism
  • Contrast Media
  • Disease Models, Animal
  • Gadolinium DTPA
  • Glioma / diagnosis*
  • Glioma / metabolism*
  • Magnetic Resonance Imaging*
  • Proto-Oncogene Proteins c-met / metabolism*

Substances

  • Albumins
  • Contrast Media
  • albumin-(gadolinium-DTPA)
  • Proto-Oncogene Proteins c-met
  • Gadolinium DTPA